Patents-Review.com
ClassID:

97194 ⎘

C07K16/2884 - CPC Classification

Classification description:

Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44

Recent Application in this class:
#1
20260069710
2026-03-12

LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF

 #2
20250340662
2025-11-06

BINDING PROTEIN

 #3
20250326855
2025-10-23

ANTI-GLYCO-CD44 ANTIBODIES AND THEIR USES

 #4
20250325665
2025-10-23

FUSION CONSTRUCTS AND METHODS OF USING THEREOF

 #5
20250255979
2025-08-14

PROCESS FOR PREPARING PURIFIED DRUG CONJUGATES

 #6
20250170256
2025-05-29

THERAPEUTIC ANTIBODY AND USES THEREOF

 #7
20250009879
2025-01-09

NATURAL KILLER CELL-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF

 #8
20240376200
2024-11-14

Improved Antibody Masking Domains

 #9
20240228618
2024-07-11

COMPOSITIONS COMPRISING A T CELL REDIRECTION THERAPEUTIC AND AN ANTI-CD44 THERAPEUTIC

 #10
20240101685
2024-03-28

NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER

 #11
20240052014
2024-02-15

TRUNCATED BODY OF IL7Ra AND USE THEREOF IN PREPARATION OF MEDICATION FOR TREATING TUMOR

 #12
20240010743
2024-01-11

THERAPEUTIC ANTIBODY AND USES THEREOF

 #13
20240009310
2024-01-11

A CHIMERIC ANTIGEN RECEPTOR CONSTRUCT ENCODING A CHECKPOINT INHIBITORY MOLECULE AND AN IMMUNE STIMULATORY CYTOKINE AND CAR-EXPRESSING CELLS RECOGNIZING CD44v6

 #14
20230322940
2023-10-12

ANTI-CD44 SINGLE-CHAIN ANTIBODY AND USE THEREOF IN PREPARING DRUG FOR TREATING TUMOR

 #15
20230295294
2023-09-21

ANTI-TIM3 SINGLE-CHAIN ANTIBODY AND USE THEREOF IN PREPARING MEDICINE FOR TREATING TUMOR

 #16
20230272103
2023-08-31

CD44-MODULATING COMPOSITIONS FOR METHODS FOR TREATING CANCERS AND ASCITES

 #17
20230192879
2023-06-22

METHODS FOR THE DIAGNOSIS AND TREATMENT OF CYTOKINE RELEASE SYNDROME

 #18
20230158168
2023-05-25

PROCESS FOR PREPARING PURIFIED DRUG CONJUGATES

 #19
20230126689
2023-04-27

ANTI-GLYCO-CD44 ANTIBODIES AND THEIR USES

 #20
20230125234
2023-04-27

ANTI CD44-CTLA4 BISPECIFIC ANTIBODIES

 #21
20230082614
2023-03-16

USE OF CD44 ANTIBODY IN PREPARATION OF MEDICINE FOR TREATING PARKINSON'S DISEASE

 #22
20220332839
2022-10-20

USE OF PRG4 TO TREAT CANCER

 #23
20220064690
2022-03-03

CELL ENGINEERING USING RNAs

 #24
20220064599
2022-03-03

CAR NK cells

 #25
20220049008
2022-02-17

Antibodies specific to CD44

 #26
20220041736
2022-02-10

Cross-species-specific single domain bispecific single chain antibody

 #27
20220023420
2022-01-27

Fusion constructs and methods of using thereof

 #28
20220002429
2022-01-06

TUMOR CELL AGGREGATION INHIBITORS' FOR TREATING CANCER

 #29
20210311034
2021-10-07

Sensor for liquid biopsy and its method of making, and method of non-invasive liquid biopsy

 #30
20210205465
2021-07-08

ABERRANT CELL-RESTRICTED IMMUNOGLOBULINS PROVIDED WITH A TOXIC MOIETY

 #31
20210205450
2021-07-08

Method for treating subject suffering from flavivirus infection

 #32
20210188928
2021-06-24

TREATMENT OF DISEASE VIA TRANSCRIPTION FACTOR MODULATION

 #33
20210087289
2021-03-25

THERAPEUTIC ANTIBODY AND USES THEREOF

 #34
20210079112
2021-03-18

COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION

 #35
20210023238
2021-01-28

TRIPTOLIDE ANTIBODY CONJUGATES

 #36
20200399359
2020-12-24

COMBINATORIAL ANTIBODY LIBRARIES AND USES THEREOF

 #37
20190315878
2019-10-17

BISPECIFIC ANTIBODIES THAT MODULATE TLR-4 SIGNALING AND USES THEREOF

 #38
20190091349
2019-03-28

Antigen responsive antibody-fluorescent dye conjugate and method for fluorescence detection and imaging of target cell using the same

 #39
20190091257
2019-03-28

Compositions and methods for restoring endothelial glycocalyx

 #40
20190076549
2019-03-14

Combinations of PBD-based antibody drug conjugates with Bcl-2 inhibitors

 #41
20190030177
2019-01-31

Process for preparing purified drug conjugates

 #42
20190023808
2019-01-24

Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for cancer

 #43
20180184950
2018-07-05

IMAGING DEVICE AND METHOD FOR DETECTION OF DISEASE

 #44
20180171015
2018-06-21

Method of Increasing GIPCR Signalization in the Cells of a Scoliotic Subject

 #45
20180154013
2018-06-07

ABERRANT CELL-RESTRICTED IMMUNOGLOBULINS PROVIDED WITH A TOXIC MOIETY

 #46
20180119191
2018-05-03

Cell engineering using MICRORNAs

 #47
20180016314
2018-01-18

TREATMENT OF DISEASE VIA TRANSCRIPTION FACTOR MODULATION

 #48
20170247417
2017-08-31

T-cell redirecting bispecific antibodies for treatment of disease

 #49
20170022274
2017-01-26

T-cell redirecting bispecific antibodies for treatment of disease

 #50
20170002090
2017-01-05

Ligand-cytotoxic drug conjugate, preparation method thereof, and uses thereof

 #51
20170000886
2017-01-05

MESENCHYMAL STEM CELLS FOR TARGETED CANCER THERAPY

 #52
20160376369
2016-12-29

Anti-EphA2 antibodies and methods of use thereof

 #53
20160368992
2016-12-22

A METHOD OF INCREASING GIPCR SIGNALIZATION IN THE CELLS OF A SCOLIOTIC SUBJECT

 #54
20160215057
2016-07-28

Method for treating and/or preventing atrial fibrillation

 #55
20160194627
2016-07-07

Combinatorial antibody libraries and uses thereof

 #56
20160176980
2016-06-23

T-cell redirecting bispecific antibodies for treatment of disease

 #57
20160130352
2016-05-12

RHAMM, A CO-RECEPTOR AND ITS INTERACTIONS WITH OTHER RECEPTORS IN CANCER CELL MOTILITY AND THE IDENTIFICATION OF CANCER PROGNITOR CELL POPULATIONS

 #58
20160045616
2016-02-18

PROCESS FOR PREPARING PURIFIED DRUG CONJUGATES

 #59
20150374848
2015-12-31

Methods for the Treatment of Head and Neck Squamous Cell Carcinoma

 #60
20150343081
2015-12-03

Anti-EphA2 antibodies and methods of use thereof

 #61
20150266940
2015-09-24

CD44 splice variants in neurodegenerative diseases

 #62
20150239979
2015-08-27

Compositions and methods

 #63
20150197575
2015-07-16

TUMOR SPECIFIC ANTIBODY

 #64
20150182635
2015-07-02

Process for preparing purified drug conjugates

 #65
20150151004
2015-06-04

METHODS AND COMPOSITIONS OF MODULATING TUMOR INITIATING CELLS AND THE USE THEREOF

 #66
20150140591
2015-05-21

CELL ENGINEERING USING RNAs

 #67
20150132322
2015-05-14

METHOD OF GENERATING HUMAN MONOCLONAL ANTIBODIES

 #68
20150056198
2015-02-26

Aberrant cell-restricted immunoglobulins provided with a toxic moiety

 #69
20150044232
2015-02-12

MARKERS FOR THE RESPONSIVENESS TO ANTI-CD44 ANTIBODIES

 #70
20140335084
2014-11-13

ANTIBODY FORMULATION

 #71
20140308301
2014-10-16

CD44 MONOCLONAL ANTIBODY FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA AND OTHER HEMATOLOGICAL MALIGNANCIES

 #72
20140050660
2014-02-20

T-cell redirecting bispecific antibodies for treatment of disease

 #73
20130224108
2013-08-29

Methods for the Treatment of Head and Neck Squamous Cell Carcinoma

 #74
20130209481
2013-08-15

Anti-tumor antigen antibodies and methods of use

 #75
20120294870
2012-11-22

Compositions and methods for diagnosis and treatment of tumors

 #76
20120201751
2012-08-09

Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44

 #77
20120107233
2012-05-03

Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44

 #78
20120058906
2012-03-08

Combinatorial antibody libraries and uses thereof

 #79
20120020880
2012-01-26

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #80
20110318339
2011-12-29

Anti-DLL4 antibodies and uses thereof

 #81
20110275787
2011-11-10

Cross-species-specific single domain bispecific single chain antibody

 #82
20110229496
2011-09-22

METHOD FOR REGULATING SURVIVAL AND MEMORY OF T HELPER 1 CELLS

 #83
20110207678
2011-08-25

CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases

 #84
20110172286
2011-07-14

CD44 splice variants in neurodegenerative diseases

 #85
20110166319
2011-07-07

PROCESS FOR PREPARING PURIFIED DRUG CONJUGATES

 #86
20110021744
2011-01-27

Process for preparing purified drug conjugates

 #87
20110009310
2011-01-13

Drug for treating states related to the inhibition of angiogenesis and/or endothelial cell proliferation

 #88
20100322950
2010-12-23

Compositions and methods for diagnosis and treatment of tumors

 #89
20100150918
2010-06-17

CROSS-SPECIES-SPECIFIC BINDING DOMAIN

 #90
20100092484
2010-04-15

CD44 ANTIBODIES

 #91
20100062000
2010-03-11

Rhamm, a Co-Receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell Populations

 #92
20100040540
2010-02-18

ANTI CD44 ANTIBODIES FOR ERADICATING LEUKAEMIC STEM CELLS AND BREAST CANCER STEM CELLS

 #93
20090214421
2009-08-27

Antibody directed against PAP2a and use thereof for diagnostic and therapeutic purposes

 #94
20090208411
2009-08-20

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #95
20090136524
2009-05-28

Compositions and methods for diagnosis and treatment of tumors

 #96
20090104202
2009-04-23

CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases

 #97
20090093053
2009-04-09

CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases

 #98
20090035257
2009-02-05

Devices, compositions and methods for the protection and repair of cells and tissues

 #99
20090004103
2009-01-01

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #100
20080274049
2008-11-06

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #101
20080219919
2008-09-11

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #102
20080138898
2008-06-12

METHODS FOR IMPROVING ANTIBODY PRODUCTION

 #103
20080131429
2008-06-05

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #104
20080124327
2008-05-29

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #105
20080112936
2008-05-15

Methods of implanting mesenchymal stem cells for tissue repair and formation

 #106
20080050391
2008-02-28

Method for Treating Autoimmune Diseases With Antibodies

 #107
20070292441
2007-12-20

CD44E tumor specific antibody

 #108
20070280930
2007-12-06

Cd44-Targeting for Reducing/Preventing Ischemia-Reperfusion-Injury

 #109
20070248538
2007-10-25

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #110
20070237761
2007-10-11

Chimeric Anti Cd44 Antibodies and Their Use for Treating Acute Myeloid Leukemia

 #111
20070207128
2007-09-06

Method for treating autoimmune diseases and compositions therefor

 #112
20070184051
2007-08-09

Anti CD44 antibodies for eradicating stem cells

 #113
20070053836
2007-03-08

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #114
20070048314
2007-03-01

Process for preparing purified drug conjugates

 #115
20060216233
2006-09-28

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #116
20060019340
2006-01-26

CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases

 #117
20050249731
2005-11-10

Methods of implating mesenchymal stem cells for tissue repair and formation

 #118
20050214283
2005-09-29

Antibodies to CD44 glycoforms and uses thereof

 #119
20050214212
2005-09-29

Antibodies specific for CD44v6

 #120
20050147606
2005-07-07

Anti CD44 antibodies for eradicating stem cells

 #121
20050100542
2005-05-12

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #122
20050054593
2005-03-10

New drug

 #123
20050008646
2005-01-13

Cytotoxicity mediation of cells evidencing surface expression of CD44